SG2189G - Compounds with dinitrogen containing heterocyclic nucleus,their process of preparation and medicines active on the central nerve system containing them - Google Patents
Compounds with dinitrogen containing heterocyclic nucleus,their process of preparation and medicines active on the central nerve system containing themInfo
- Publication number
- SG2189G SG2189G SG21/89A SG2189A SG2189G SG 2189 G SG2189 G SG 2189G SG 21/89 A SG21/89 A SG 21/89A SG 2189 A SG2189 A SG 2189A SG 2189 G SG2189 G SG 2189G
- Authority
- SG
- Singapore
- Prior art keywords
- compounds
- preparation
- central nerve
- nerve system
- heterocyclic nucleus
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 229940079593 drug Drugs 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 title abstract 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 title 1
- 229910001873 dinitrogen Inorganic materials 0.000 title 1
- 210000005036 nerve Anatomy 0.000 title 1
- MDFFNEOEWAXZRQ-UHFFFAOYSA-N aminyl Chemical compound [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/20—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Catalysts (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Polymerisation Methods In General (AREA)
- Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8300954A FR2539741A1 (fr) | 1983-01-21 | 1983-01-21 | Composes a noyau heterocyclique diazote, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG2189G true SG2189G (en) | 1989-06-02 |
Family
ID=9285183
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG21/89A SG2189G (en) | 1983-01-21 | 1989-01-11 | Compounds with dinitrogen containing heterocyclic nucleus,their process of preparation and medicines active on the central nerve system containing them |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US4624952A (cs) |
| EP (1) | EP0114770B1 (cs) |
| JP (1) | JPS59137469A (cs) |
| KR (1) | KR910000640B1 (cs) |
| AT (1) | ATE28453T1 (cs) |
| AU (1) | AU563160B2 (cs) |
| CA (1) | CA1217490A (cs) |
| CS (1) | CS242894B2 (cs) |
| DD (1) | DD216014A5 (cs) |
| DE (1) | DE3464909D1 (cs) |
| DK (1) | DK25684A (cs) |
| EG (1) | EG16212A (cs) |
| ES (1) | ES528921A0 (cs) |
| FI (1) | FI79537C (cs) |
| FR (1) | FR2539741A1 (cs) |
| GR (1) | GR79766B (cs) |
| HU (1) | HU191586B (cs) |
| IE (1) | IE56569B1 (cs) |
| IL (1) | IL70740A (cs) |
| MA (1) | MA20007A1 (cs) |
| NO (1) | NO159170C (cs) |
| NZ (1) | NZ206906A (cs) |
| OA (1) | OA07638A (cs) |
| PH (1) | PH21060A (cs) |
| PL (1) | PL143224B1 (cs) |
| PT (1) | PT77966B (cs) |
| SG (1) | SG2189G (cs) |
| SU (1) | SU1342415A3 (cs) |
| YU (1) | YU10384A (cs) |
| ZA (1) | ZA84342B (cs) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5001125A (en) * | 1984-03-26 | 1991-03-19 | Janssen Pharmaceutica N.V. | Anti-virally active pyridazinamines |
| FR2567518B1 (fr) * | 1984-07-11 | 1987-11-13 | Sanofi Sa | Nouveaux composes a noyau heterocyclique azote, leur preparation et les medicaments qui en contiennent |
| DE3517617A1 (de) * | 1985-05-15 | 1986-11-20 | Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München | Neue pyridaziniumverbindungen, verfahren zu deren herstellung und diese enthaltende fungizide und algizide mittel |
| US5106973A (en) * | 1987-11-23 | 1992-04-21 | Janssen Pharmaceutica N.V. | Pyridzainamine derivatives |
| FI895821A7 (fi) * | 1988-12-07 | 1990-06-08 | The Wellcome Foundation Ltd | Farmaseuttisesti aktivisia CNS-yhdisteitä |
| US5631255A (en) * | 1989-02-07 | 1997-05-20 | Sanofi | Pyridazine derivatives |
| FR2676444B1 (fr) * | 1991-05-16 | 1995-03-10 | Sanofi Elf | Nouveaux derives d'amino-3 pyridazines actifs sur le systeme nerveux central, procede de preparation et compositions pharmaceutiques en contenant. |
| TW440563B (en) * | 1996-05-23 | 2001-06-16 | Hoffmann La Roche | Aryl pyrimidine derivatives and a pharmaceutical composition thereof |
| US5952331A (en) * | 1996-05-23 | 1999-09-14 | Syntex (Usa) Inc. | Aryl pyrimidine derivatives |
| US5958934A (en) * | 1996-05-23 | 1999-09-28 | Syntex (U.S.A.) Inc. | Aryl pyrimidine derivatives and uses thereof |
| US8575167B2 (en) * | 2007-02-06 | 2013-11-05 | Takeda Pharmaceutical Company Limited | Spiro compounds having stearoyl-CoA desaturase action |
| US10494373B2 (en) * | 2015-04-29 | 2019-12-03 | Guangdong Zhongsheng Pharmaceutical Co., Ltd | Fused-ring or tricyclic aryl pyrimidine compound used as kinase inhibitor |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1345880A (en) * | 1971-06-18 | 1974-02-06 | Cepbepe | Pyridazine derivatives |
| US4302455A (en) * | 1980-04-14 | 1981-11-24 | Merck & Co., Inc. | 2-(4-Aminopiperidino)pyrazines |
| FR2510997A1 (fr) * | 1981-08-10 | 1983-02-11 | Sanofi Sa | Nouveaux derives de la methyl-4 phenyl-6 pyridazine, procede pour leur preparation et medicaments actifs sur le systeme nerveux central en contenant |
| FR2511366A1 (fr) * | 1981-08-11 | 1983-02-18 | Sanofi Sa | Nouveaux derives de la pyridazine, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent |
-
1983
- 1983-01-21 FR FR8300954A patent/FR2539741A1/fr active Granted
-
1984
- 1984-01-12 AU AU23236/84A patent/AU563160B2/en not_active Ceased
- 1984-01-12 CA CA000445186A patent/CA1217490A/en not_active Expired
- 1984-01-13 MA MA20228A patent/MA20007A1/fr unknown
- 1984-01-16 GR GR73515A patent/GR79766B/el unknown
- 1984-01-16 US US06/570,832 patent/US4624952A/en not_active Expired - Fee Related
- 1984-01-16 PT PT77966A patent/PT77966B/pt not_active IP Right Cessation
- 1984-01-17 ZA ZA84342A patent/ZA84342B/xx unknown
- 1984-01-17 ES ES528921A patent/ES528921A0/es active Granted
- 1984-01-18 AT AT84400101T patent/ATE28453T1/de not_active IP Right Cessation
- 1984-01-18 IE IE102/84A patent/IE56569B1/en not_active IP Right Cessation
- 1984-01-18 DE DE8484400101T patent/DE3464909D1/de not_active Expired
- 1984-01-18 EP EP84400101A patent/EP0114770B1/en not_active Expired
- 1984-01-19 DD DD84259497A patent/DD216014A5/de not_active IP Right Cessation
- 1984-01-19 CS CS84424A patent/CS242894B2/cs unknown
- 1984-01-20 PL PL1984245836A patent/PL143224B1/pl unknown
- 1984-01-20 YU YU00103/84A patent/YU10384A/xx unknown
- 1984-01-20 OA OA58210A patent/OA07638A/xx unknown
- 1984-01-20 NZ NZ206906A patent/NZ206906A/en unknown
- 1984-01-20 IL IL70740A patent/IL70740A/xx unknown
- 1984-01-20 SU SU843696574A patent/SU1342415A3/ru active
- 1984-01-20 PH PH30134A patent/PH21060A/en unknown
- 1984-01-20 NO NO840214A patent/NO159170C/no unknown
- 1984-01-20 DK DK25684A patent/DK25684A/da not_active Application Discontinuation
- 1984-01-20 FI FI840238A patent/FI79537C/fi not_active IP Right Cessation
- 1984-01-20 HU HU84246A patent/HU191586B/hu not_active IP Right Cessation
- 1984-01-20 KR KR1019840000249A patent/KR910000640B1/ko not_active Expired
- 1984-01-21 JP JP59009383A patent/JPS59137469A/ja active Pending
- 1984-01-21 EG EG40/84A patent/EG16212A/xx active
-
1989
- 1989-01-11 SG SG21/89A patent/SG2189G/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3464909D1 (en) | Compounds with dinitrogen containing heterocyclic nucleus, their process of preparation and medicines active on the central nerve system containing them | |
| FR2320300A1 (fr) | Procede de preparation de chromanones-(4) | |
| DE2860988D1 (en) | Process for the fractional desublimation of dianhydride of 1,2,4,5-benzenetetracarboxylic acid | |
| ES460286A1 (es) | Un procedimiento de preparacion de espiro(1,3-dioxolan-4,3) quinuclidina. | |
| BE843199A (fr) | Procede de preparation de 2,4-dioxo-1,2,3,4-tetrahydro-s-triazino-(1,2-a)-benzimidazoles | |
| PT67096B (en) | Process for the preparation of n-substituted bis-carbamoylsulfide compounds | |
| BE844943A (fr) | Procede de preparation de chromanones-(4) | |
| FR2327995A1 (fr) | Procede ameliore de preparation de vanadate d'ethyle | |
| BE845327A (fr) | Procede de preparation de 4,4'-dihydroxy-3-3'-5-5'-tretralcoyldiphenylalcanes | |
| BE837906A (fr) | Procede de preparation de n-(alpha-alcoxyethyl)-carboxamides | |
| OA05206A (fr) | Procédé de préparation de dérivés d'amines. | |
| ES8708134A1 (es) | Un procedimiento para la preparacion de derivados de homocisteina-tiolactona | |
| FR2317307A1 (fr) | Procede de preparation d'oxaphospholannes-1,2 | |
| FR2321479A1 (fr) | Procede de preparation de dinitro-2,4 aniline | |
| BE844257A (fr) | Procede de preparation de 7,8-epoxy-2-methyloctadecane | |
| FR2336377A1 (fr) | Procede de preparation de la n-(3,4-dimethylphenyl)-d-ribamine | |
| AU5165579A (en) | Derivatives of n-substituted cyclic amines | |
| FR2336373A1 (fr) | Procede de preparation de 6,6,6-trihalo-3,3-dimethyl-4-hexenoates | |
| BE849390A (fr) | Procede de preparation de la n-(3,4-dimethylphenyl)-d-ribamine | |
| BE860921A (fr) | Procede de preparation d'amines aromatiques | |
| BE587137A (fr) | Procédé de préparation d'amides aromatiques ortho-disubstituées. | |
| RO76082A (fr) | Procede pour la preparation des anilines n-substitues | |
| FR2297198A1 (fr) | Procede de preparation d'alcoxytetrabromo-octanes |